product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
NQO1 (A180) Mouse mAb
catalog :
3187
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
A180
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry
citations: 11
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; loading ...; fig 3a
Brea R, Valdecantos P, Rada P, Alen R, García Monzón C, Bosca L, et al. Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress. Aging (Albany NY). 2021;13:7800-7827 pubmed publisher
  • western blot; human; fig 6a
Huang D, Dai C, Li S, Li X. Obacunone protects retinal pigment epithelium cells from ultra-violet radiation-induced oxidative injury. Aging (Albany NY). 2021;13:11010-11025 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 8c, s11e
Yang Y, Willis T, Button R, Strang C, Fu Y, Wen X, et al. Cytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate Nrf2-mediated stress response. Nat Commun. 2019;10:3759 pubmed publisher
  • western blot; human; loading ...; fig 2A; 2C
Cheng L, Li K, Yi N, Li X, Wang F, Xue B, et al. miRNA-141 attenuates UV-induced oxidative stress via activating Keap1-Nrf2 signaling in human retinal pigment epithelium cells and retinal ganglion cells. Oncotarget. 2017;8:13186-13194 pubmed publisher
  • western blot; human; 1:3000; fig 2
Tian Y, Wu K, Liu Q, Han N, Zhang L, Chu Q, et al. Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer. J Hematol Oncol. 2016;9:83 pubmed publisher
  • western blot; human; fig 8
Furuya A, Sharifi H, Jellinger R, Cristofano P, Shi B, de Noronha C. Sulforaphane Inhibits HIV Infection of Macrophages through Nrf2. PLoS Pathog. 2016;12:e1005581 pubmed publisher
  • western blot; human; loading ...; fig 6a
Liu X, Ward K, Xavier C, Jann J, Clark A, Pang I, et al. The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation. Redox Biol. 2016;8:98-109 pubmed publisher
  • immunocytochemistry; rat; 1:100
  • western blot; rat
Xiong R, Siegel D, Ross D. Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicity. Toxicol Appl Pharmacol. 2014;280:285-95 pubmed publisher
Kasai S, Arakawa N, Okubo A, Shigeeda W, Yasuhira S, Masuda T, et al. NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG. PLoS ONE. 2016;11:e0153181 pubmed publisher
Sahdeo S, Scott B, McMackin M, Jasoliya M, Brown B, Wulff H, et al. Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia. Hum Mol Genet. 2014;23:6848-62 pubmed publisher
Lam K, Zheng X, Forestieri R, Balgi A, Nodwell M, Vollett S, et al. Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. PLoS Pathog. 2012;8:e1002691 pubmed publisher
product information
SKU :
3187S
Product-Name :
NQO1 (A180) Mouse mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Metabolism
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
29
Host :
Mouse
Target :
NQO1
Primary-Protein :
NQO1
Alt-Names :
Azoreductase,DHQU,DIA4,DT-diaphorase,DTD,Menadione reductase,NAD(P)H dehydrogenase [quinone] 1,NAD(P)H dehydrogenase, quinone 1,NAD(P)H:Quinone acceptor oxidoreductase type 1,NAD(P)H:menadione oxidoreductase 1,NAD(P)H:quinone oxidoreductase 1,NAD(P)H:quinone oxireductase,NMOR1,NMORI,NQO1,Phylloquinone reductase,QR1,Quinone reductase 1,diaphorase (NADH/NADPH) (cytochrome b-5 reductase),diaphorase-4,dioxin-inducible 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.